Antiperspirant products with protein and antiperspirant salts
US-9827177-B2 · Nov 28, 2017 · US
Therapeutic oral composition
US9579269B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9579269-B2 |
| Application number | US-201013701844-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 23, 2010 |
| Priority date | Jun 23, 2010 |
| Publication date | Feb 28, 2017 |
| Grant date | Feb 28, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are therapeutic oral compositions useful in the treatment of a variety of oral disorders, in which the composition can provide blockage of dentinal tubes, while at the same time provide antibacterial and anti-caries efficacy. The compositions include arginine in free or salt form, a mucoadhesive polymer, and at least one component selected from pyrophosphates, zinc salts, potassium salts, strontium salts, and mixtures thereof.
First claim
Opening claim text (preview).
We claim: 1. An oral care composition comprising arginine in free or salt form, wherein the arginine compound is present in an amount within the range of from 0.6% to 1% by weight, a mucoadhesive polymer which is a polyvinylmethylether/maleic anhydride (PVME/MA) copolymer, a pyrophosphate compound comprising tetrasodium pyrophosphate and tetrapotassium pyrophosphate, a zinc salt comprising zinc citrate; and wherein the oral care composition is abrasive free. 2. The composition as claimed in claim 1 , wherein the arginine compound is present in an amount within the range of from 0.75% to 0.9% by weight. 3. The composition as claimed in claim 1 , wherein the polyvinylmethylether/maleic anhydride (PVME/MA) copolymer is present in an amount within the range of from 0.1% to 20% by weight. 4. The composition as claimed in claim 1 , further comprising an antibacterial agent. 5. The composition as claimed in claim 1 , wherein the composition is in a form selected from the group consisting of a mouthwash, a dental gel, a periodontal gel and a liquid suitable for painting a dental surface. 6. The composition as claimed in claim 5 , wherein the composition is a mouthwash. 7. The composition as claimed in claim 1 , wherein the composition has a flow reduction above 60%, when measured using a hydraulic conductance test. 8. An article comprising packaging material and the composition as claimed in claim 1 , wherein the packaging material comprises a label that indicates the oral composition is effective in retarding dentinal hypersensitivity.
Assignees
Inventors
Classifications
Antibacterial agents · CPC title
Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis · CPC title
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title
Zinc; Compounds thereof · CPC title
Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9579269B2 cover?
- Disclosed are therapeutic oral compositions useful in the treatment of a variety of oral disorders, in which the composition can provide blockage of dentinal tubes, while at the same time provide antibacterial and anti-caries efficacy. The compositions include arginine in free or salt form, a mucoadhesive polymer, and at least one component selected from pyrophosphates, zinc salts, potassium sa…
- Who is the assignee on this patent?
- Mello Sarita V, Arvanitidou Evangelia, Colgate Palmolive Co
- What technology area does this patent fall under?
- Primary CPC classification A61K8/00. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).